Share class: DiaSorin S.p.A.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A155,948,25721,167,311 ( 37.83 %) 2,632,381 ( 4.705 %) 37.83 %

Major shareholders: DiaSorin S.p.A.

NameEquities%Valuation
IP Investimenti e Partecipazioni SRL
43.96 %
24,593,454 43.96 % 2 831 M €
Carlo Rosa
8.363 %
4,679,214 8.363 % 539 M €
2,350,000 4.200 % 271 M €
DiaSorin SpA
2.979 %
1,666,698 2.979 % 192 M €
570,000 1.019 % 66 M €
Shareholder Value Management AG
0.8921 %
499,100 0.8921 % 57 M €
Mediolanum Gestione Fondi SGRpA
0.6682 %
373,832 0.6682 % 43 M €
FIL Investments International (Italy)
0.2457 %
137,471 0.2457 % 16 M €
Fideuram Asset Management SGR SpA
0.2029 %
113,519 0.2029 % 13 M €
Myria Asset Management SASU
0.1204 %
67,339 0.1204 % 8 M €
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional47.83%
Individuals13.58%
DiaSorin SpA2.98%
Unknown35.61%

Based on 1000 largest holdings

Geographical origin of shareholders

Italy 48.76%
Individuals 13.58%
Germany 0.95%
France 0.34%
United Kingdom 0.19%
Finland 0.12%
Norway 0.08%
Luxembourg 0.08%
Sweden 0.06%
Switzerland 0.05%
Ireland 0.04%
Portugal 0.04%
Netherlands 0.02%
Austria 0.02%
New Zealand 0.01%
United States 0.01%
Denmark 0.01%
Japan 0.01%
Spain 0.01%

Based on 1000 largest holdings

Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Employees
3,186
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW